Dennis M. Mcgrath - 10 Oct 2023 Form 4 Insider Report for Citius Pharmaceuticals, Inc. (CTXR)

Role
Director
Signature
/s/ Alexander M. Donaldson, by power of attorney
Issuer symbol
CTXR
Transactions as of
10 Oct 2023
Net transactions value
$0
Form type
4
Filing time
12 Oct 2023, 16:15:26 UTC
Previous filing
09 Feb 2023
Next filing
08 Mar 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTXR Options to Purchase Common Stock Award $0 +75,000 $0.000000 75,000 10 Oct 2023 Common Stock 75,000 $0.7000 Direct F1
holding CTXR Options to Purchase Common Stock 75,000 10 Oct 2023 Common Stock 75,000 $1.42 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were granted on October 10, 2023. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date.
F2 The options were granted on February 7, 2023. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date.